Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

for
Metastatic Breast Cancer
Location: Moncton, Boston MA, Quebec, Montreal, Hyattsville MD,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05894239

Phase 3, Recruiting

Barrett's Esophagus Related Neoplasia (BERN) Project

for
Barrett's Esophagus, Neoplasms, Gastroesophageal Reflux
Location: Kansas City MO
Sponsor: Midwest Biomedical Research Foundation

Sex: All

Age: 18+

Code: NCT00590239

Recruiting

Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases

for
Metastatic Malignant Neoplasm in the Brain,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT06328686

Early Phase 1, Recruiting

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors

for
Brain and Central Nervous System Tumors, Metastatic Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 3 - 70

Code: NCT00002647

Phase 1, Recruiting

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

for
Acquired Immunodeficiency Syndrome, BK Virus Infection,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT02479698

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Postoperative Analgesia Intervention With Non-opioid Alternatives (PAIN-Alt) Trial - Breast Surgery

for
Post Operative Pain, Opioid Analgesic Adverse Reaction, Surgery,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre

Sex: All

Age: 18+

Code: NCT06507345

Recruiting

Clinical Trial of PM54 in Advanced Solid Tumors Patients.

for
Advanced Solid Tumor
Location: San Antonio TX
Sponsor: PharmaMar

Sex: All

Age: 18+

Code: NCT05841563

Phase 1, Recruiting

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

for
Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma,
Location: Boston MA, Fairfax VA, Pittsburgh PA, Dallas TX
Sponsor: ImmVira Pharma Co. Ltd

Sex: All

Age: 18+

Code: NCT04370587

Phase 1, Phase 2, Recruiting

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

for
Endometrial Cancer, Cervical Cancer, Ovarian Cancer,
Location: Boston MA, Mineola NY, Lake Success NY, New York NY,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06293898

Phase 1, Recruiting

ALIGN for Older Adults With Cancer in SNFs

for
Advanced Cancer
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT06616298

Recruiting

Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab

for
Stage I-IV Breast Cancer (Neo-adjuvant, Adjuvant, Locally Advanced and Metastatic),
Location: Toronto
Sponsor: Unity Health Toronto

Sex: All

Age: 18+

Code: NCT01022086

Recruiting

ALG.APV-527 First-in-human Study

for
Solid Tumor
Location: Port Saint Lucie FL
Sponsor: Aptevo Therapeutics

Sex: All

Age: 18+

Code: NCT05934539

Phase 1, Phase 2, Recruiting

Collection of Tissue Samples for Cancer Research

for
Neoplasms, Lymphomas, Multiple Myeloma,
Location: Baltimore MD, Bethesda MD, Buffalo NY, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT00900198

Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,
Location: The Bronx NY, Norfolk VA, Rockville MD, Miami FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase 3, Recruiting

Aerobic Exercise and Cognitive Functioning in Women With Breast Cancer

for
Breast Neoplasms
Location: Ottawa, Vancouver
Sponsor: University of British Columbia

Sex: Female

Age: 19 - 70

Code: NCT03277898

Recruiting

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors

for
Advanced Solid Tumor, Homologous Recombination Deficiency,
Location: Durham NC, Shreveport LA, Houston TX, Seattle WA
Sponsor: Eisbach Bio GmbH

Sex: All

Age: 18+

Code: NCT06525298

Phase 1, Phase 2, Recruiting

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

for
Lung Cancer, Non-small Cell, Lung Cancer Metastatic,
Location: Weston FL, Canton OH, Cleveland OH, Detroit MI,
Sponsor: Krystal Biotech, Inc.

Sex: All

Age: 18+

Code: NCT06228326

Phase 1, Phase 2, Recruiting

Patient Navigation to Improve Patient-Centered Cancer Care

for
Cancer
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT03226405

Recruiting

A Crowd Sourcing Platform for Patients With Cancer

for
Cancer
Location: Seattle WA
Sponsor: All4Cure

Sex: All

Age: 18+

Code: NCT03530826

Recruiting

Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting

for
Infertility, Male, Cancer, Autoimmune Disorder
Location: Pittsburgh PA
Sponsor: University of Pittsburgh

Sex: Male

Age: 0+

Code: NCT04452305

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial